Cargando…

Identification and validation of miR-509-5p as a prognosticator for favorable survival in osteosarcoma

Osteosarcoma (OS) is the most common primary bone cancer diagnosed in children. This study aims to explore the aberrantly expressed miRNAs that are prognostically related and to provide potential biomarkers for the prognosis prediction of OS. The miRNA profiles of OS and adjacent normal controls wer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Jiekun, Fang, Xiang, Zhou, Jun, Zeng, LingGuo, Yu, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387993/ https://www.ncbi.nlm.nih.gov/pubmed/35984199 http://dx.doi.org/10.1097/MD.0000000000029705

Ejemplares similares

miR-509-5p Inhibits the Proliferation and Invasion of Osteosarcoma by Targeting TRIB2
por: Guo, Jiekun, et al.
Publicado: (2019)

Retracted: miR-509-5p Inhibits the Proliferation and Invasion of Osteosarcoma by Targeting TRIB2
por: Research International, BioMed
Publicado: (2021)

Diagnostic and prognostic implications of serum miR-101 in osteosarcoma
por: Yao, Z.-S., et al.
Publicado: (2018)

miR-509-5p and miR-1243 increase the sensitivity to gemcitabine by inhibiting epithelial-mesenchymal transition in pancreatic cancer
por: Hiramoto, Hidekazu, et al.
Publicado: (2017)

miR-509-3-5P inhibits the invasion and lymphatic metastasis by targeting PODXL and serves as a novel prognostic indicator for gastric cancer
por: Zhang, Jing, et al.
Publicado: (2017)

Serum miR-95-3p is a diagnostic and prognostic marker for osteosarcoma
por: Niu, Junjie, et al.
Publicado: (2016)

miR-509 inhibits cancer stemness properties in oral carcinomas via directly targeting PlK1
por: Lu, Ming-Yi, et al.
Publicado: (2022)

Preserved miR-361-3p Expression Is an Independent Prognostic Indicator of Favorable Survival in Cervical Cancer
por: Liu, Shikai, et al.
Publicado: (2018)

Evaluation of the Expression of miR-486-3p, miR-548-3p, miR-561-5p and miR-509-5p in Tumor Biopsies of Patients with Oral Squamous Cell Carcinoma
por: Garajei, Ata, et al.
Publicado: (2022)

miR-509 suppresses brain metastasis of breast cancer cells by modulating RhoC and TNF α
por: Xing, Fei, et al.
Publicado: (2015)

MiR-509-3 augments the synthetic lethality of PARPi by regulating HR repair in PDX model of HGSOC
por: Sun, Chenggong, et al.
Publicado: (2020)

MicroRNA miR-509-3p inhibit metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma
por: Zhang, Huiming, et al.
Publicado: (2021)

Serum miR-300 as a diagnostic and prognostic biomarker in osteosarcoma
por: Liu, Jian-Dong, et al.
Publicado: (2016)

LncRNA HOXA-AS2 promotes the progression of prostate cancer via targeting miR-509-3p/PBX3 axis
por: Xiao, Shangwen, et al.
Publicado: (2020)

Biomarker significance of plasma and tumor miR-21, miR-221, and miR-106a in osteosarcoma
por: Nakka, Manjula, et al.
Publicado: (2017)

miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer
por: Pan, Yinghong, et al.
Publicado: (2016)

MicroRNA miR-509 Regulates ERK1/2, the Vimentin Network, and Focal Adhesions by Targeting Plk1
por: Liao, Guoning, et al.
Publicado: (2018)

miR-509-5p inhibits cellular proliferation and migration via targeting MDM2 in pancreatic cancer cells
por: Li, Xin, et al.
Publicado: (2017)

MiR-509-5p improves the proliferative and invasive abilities of papillary thyroid carcinoma cells by inhibiting SFRP1
por: Yang, Chunxiao, et al.
Publicado: (2019)

miR-1270 enhances the proliferation, migration, and invasion of osteosarcoma via targeting cingulin
por: Liu, Yang, et al.
Publicado: (2021)

MiR-34a and miR-203 Inhibit Survivin Expression to Control Cell Proliferation and Survival in Human Osteosarcoma Cells
por: Chen, Xun, et al.
Publicado: (2016)

miR-143-3p inhibits the proliferation, migration and invasion in osteosarcoma by targeting FOSL2
por: Sun, Xiangran, et al.
Publicado: (2018)

Expression of miR-664 and miR-184 on proliferation, apoptosis and migration of osteosarcoma cells
por: Tao, Pengfei, et al.
Publicado: (2019)

Regulation of RAB5C Is Important for the Growth Inhibitory Effects of MiR-509 in Human Precursor-B Acute Lymphoblastic Leukemia
por: Tan, Yee Sun, et al.
Publicado: (2014)

Correction: miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer
por: Pan, Yinghong, et al.
Publicado: (2017)

Prognostic factors to survival of patients with chondroblastic osteosarcoma
por: Sun, Hui-Hui, et al.
Publicado: (2018)

The Tumor Suppressor Role of miR-124 in Osteosarcoma
por: Geng, Shuo, et al.
Publicado: (2014)

LncRNA ASAP1-IT1 enhances cancer cell stemness via regulating miR-509-3p/YAP1 axis in NSCLC
por: Liu, Yantao, et al.
Publicado: (2021)

miR-149-5p inhibits cell growth by regulating TWEAK/Fn14/PI3K/AKT pathway and predicts favorable survival in human osteosarcoma
por: Xu, Rui-Da, et al.
Publicado: (2018)

miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells
por: Salah, Zaidoun, et al.
Publicado: (2015)

miR-125b and miR-100 Are Predictive Biomarkers of Response to Induction Chemotherapy in Osteosarcoma
por: Kubota, Daisuke, et al.
Publicado: (2016)

miR-335 negatively regulates osteosarcoma stem cell-like properties by targeting POU5F1
por: Guo, Xiaodong, et al.
Publicado: (2017)

MiR-509-3p is oncogenic, targets the tumor suppressor PHLPP2, and functions as a novel tumor adjacent normal tissue based prognostic biomarker in colorectal cancer
por: Iyer, Deepak Narayanan, et al.
Publicado: (2022)

LncRNA PLAC 2 Is Downregulated in Osteosarcoma and Regulates Cancer Cell Proliferation Through miR-93
por: Sun, Xiangran, et al.
Publicado: (2020)

miR-155 inhibitor reduces the proliferation and migration in osteosarcoma MG-63 cells
por: LV, HUICHENG, et al.
Publicado: (2014)

MiR-429 suppresses the progression and metastasis of osteosarcoma by targeting ZEB1
por: Deng, Yi, et al.
Publicado: (2017)

Fludarabine treatment favors the retention of miR-485-3p by prostate cancer cells: implications for survival
por: Lucotti, Serena, et al.
Publicado: (2013)

miR‐200c and phospho‐AKT as prognostic factors and mediators of osteosarcoma progression and lung metastasis
por: Berlanga, Pablo, et al.
Publicado: (2016)

MicroRNA-509-3p inhibits cellular migration, invasion, and proliferation, and sensitizes osteosarcoma to cisplatin
por: Patil, Sagar L., et al.
Publicado: (2019)

Inhibition of Cell Proliferation and Migration by miR-509-3p That Targets CDK2, Rac1, and PIK3C2A
por: Yoon, Sena, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_i7c69a8umm1aajbi3oehji6nio